Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
about
Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Personalized Active Immunother ...... nitial Treatment With Lymphoma
@en
type
label
Personalized Active Immunother ...... nitial Treatment With Lymphoma
@en
prefLabel
Personalized Active Immunother ...... nitial Treatment With Lymphoma
@en
P6153
P1050
P1476
A Phase 2 Multi-Center, Open-L ...... mab and Chemotherapy (R-Chemo)
@en
P3098
NCT00510471
P4844
P580
2007-05-01T00:00:00Z